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Early inductive events in mammalian nephrogenesis depend on an interaction between the ureteric bud and the metanephric mesenchyme.
However, mounting evidence points towards an involvement of additional cell types – such as stromal cells and angioblasts – in growth and
patterning of the nephron. In this study, through analysis of the stem cell factor (SCF)/c-kit ligand receptor pair, we describe an additional distinct
cell population in the early developing kidney. While SCF is restricted to the ureteric bud, c-kit-positive cells are located within the renal
interstitium, but are negative for Foxd1, an established marker of stromal cells. In fact, the c-kit-positive domain is continuous with a central
mesodermal cell mass ventral and lateral to the dorsal aorta, while Foxd1-expressing stromal cells are continuous with a dorsal perisomitic cell
population suggesting distinct intraembryonic origins for these cell types. A subset of c-kit-positive cells expresses Flk-1 and podocalyxin,
suggesting that this cell population includes angioblasts and their progenitors. c-kit activation is not required for the survival of these cells in vivo,
because white spotting (c-kitW/W) mice, carrying a natural inactivating mutation of c-kit, display normal intrarenal distribution of the c-kit-positive
cells at E13.5. In addition, early kidney development in these mutants is preserved up to the stage when anemia compromises global embryonic
development. In contrast, under defined conditions in organ cultures of metanephric kidneys, c-kit-positive cells, including the Flk-1-positive
subset, undergo apoptosis after treatment with STI-571, an inhibitor of c-kit tyrosine phosphorylation. This is associated with reductions in ureteric
bud branching and nephron number. Conversely, exogenous SCF expands the c-kit-positive population, including Flk-1-positive angioblasts, and
accelerates kidney development in vitro. These data suggest that ureteric bud-derived SCF elicits growth-promoting effects in the metanephric
kidney by expanding one or more components of the interstitial c-kit-positive progenitor pool.
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Development of the adult mammalian kidney (metanephros)
involves multiple tissue interactions. At E10.5 of mouse
development, a region of the posterior intermediate mesodermAbbreviations: AGM, aorta-gonad-mesonephros; Cl, cloaca; DA, dorsal
aorta; DMEM, Dulbecco's modified Eagle's medium; DNA, desoxyribonucleic
acid; GDNF, glial derived neuronotrophic factor; Gn, gonad; HM, hindgut-
associated mesenchyme; MM, metanephric mesenchyme; ND, nephric duct;
PBS, phosphate buffered saline; PCR, polymerase chain reaction; Podxl,
podocalyxin-like protein; Raldh2, retinaldehyde dehydrogenase 2; SCF, stem
cell factor; sFRP1, secreted frizzled-related protein 1; UB, ureteric bud; UR,
urogenital ridge; W, white spotting.
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doi:10.1016/j.ydbio.2006.07.026is specified by unknown signals to evolve into the metanephric
mesenchyme. This cell population is characterized by a distinct
set of transcription factors (e.g. Pax-2, WT-1, Six-2) and
secretion of glial derived neurotrophic factor (GDNF) (Dressler,
2002; Sakurai, 2003). GDNF signals to the adjacent nephric
duct and induces outgrowth of the ureteric bud through
activation of the receptor tyrosine kinase Ret (Shah et al.,
2004; Shakya et al., 2005; Vega et al., 1996). The ureteric bud in
turn secretes factors (such as interleukin-6 cytokines, lipocalin
2, transforming growth factor β2, and Wnt-9b) that induce
conversion of the metanephric mesenchyme into epithelia of the
nephron (Barasch et al., 1999; Carroll et al., 2005; Mori et al.,
2003; Plisov et al., 2001; Schmidt-Ott et al., 2005, 2006; Yang
et al., 2002). This reciprocal interaction is fundamental for
establishing the primitive nephron, wherein structures from
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mesenchyme and the collecting system, renal pelvis, and ureter
are derived from the ureteric bud.
Recently, additional cell types have been demonstrated to
participate in development of the nephron. Foxd1-expressing
stromal cells have been demonstrated to provide critical signals
to regulate the branching pattern of the ureteric bud. Kidneys
from Foxd1-deficient mice display growth retardation and
patterning defects (Hatini et al., 1996; Levinson et al., 2005).
Additionally, a retinoid-dependent stromal signal regulates the
phenotype of the ureteric bud tip cells (Batourina et al., 2001).
Furthermore, Flk-1-expressing angioblasts are located in close
apposition to the developing nephron precursors (Robert et al.,
1998; Tufro et al., 1999) and have recently been shown to regulate
GDNF expression in metanephric mesenchyme thereby mod-
ulating ureteric bud growth and branching (Gao et al., 2005).
In this study, we describe a novel intrarenal cell population
marked by expression of the receptor tyrosine kinase c-kit.
Using a microarray-based screen for secreted factors from the
ureteric bud, we recently found stem cell factor (SCF), the
ligand of c-kit, to be specifically expressed in the ureteric bud
(Schmidt-Ott et al., 2005). This pathway classically targets
developing melanocytes, germ cells and hematopoietic pro-
genitors, but the targets of SCF in the developing kidney are
unknown (Anderson et al., 1990; Huang et al., 1990; Roskoski,
2005). We find that c-kit is expressed in a domain of cells that is
largely distinct from the known cell types of the developing
metanephros, but includes a subpopulation of Flk1- and
podocalyxin-positive angioblasts. SCF signaling is not essential
for survival of this intrarenal c-kit-positive cell population in
vivo, but in growth factor-depleted organ cultures of metaneph-
ric kidneys, exogenous SCF expands the c-kit positive cell
population, including intrarenal angioblasts, and it potentiates
growth of the developing kidney explant. Conversely, c-kit
antagonism leads to apoptosis of c-kit positive cells, which is
associated with growth defects of the nephron and the ureteric
bud in vitro. Hence, we propose that ureteric bud-derived SCF
expands a pool of c-kit-positive interstitial progenitors thereby
modulating kidney development.
Materials and methods
Reagents
Recombinant mouse SCF was from R&D Systems (Minneapolis, MN). STI-
571 (Glivec®) was from Novartis Oncology (East Hanover, NJ). ACK45
monoclonal c-kit neutralizing antibody and a species-matched isotype control
(Rat IgG2b, κ) was from BD Pharmingen.
Kidney organ culture
Embryonic kidneys or urogenital sheets containing kidneys, nephric ducts
and gonads were microdissected from E12.5 mice and placed on filters (Corning
Transwell®-Clear, 0.4 μm pore size) and grown in DMEM/F12 with holo-
transferrin (20 μg/ml) and ascorbic acid (3.8 μg/ml) supplemented with growth
factors and inhibitors as indicated. Right and left kidneys from a given embryo
were matched and assigned to different experimental conditions to correct for
variability between individual embryos. In addition, we chose to use E12.5
mouse kidneys because their development is highly reproducible even in our
growth factor-depleted media, whereas culture of earlier stages of developmentin the mouse showed a high degree of variation in growth effects in the absence
of serum.
Mouse strains and genotyping
Embryonic day 0.5 (E0.5) was considered to be at noon on the day of the
plug. Foxd1lacZ/+ mice (Hatini et al., 1996; Levinson et al., 2005), a generous gift
from Eseng Lai, were maintained in the Swiss-Webster genetic background.
Foxd1lacZ/+ mice were mated to wildtype littermates to produce 50% embryos
harboring the Foxd1lacZ/+ genotype. Genotyping was performed by X-gal stain-
ing of heads. c-kitW/+ mice (WB/ReJ KitW/+) were obtained from The Jackson
Laboratory (Bar Harbor, Maine). Mothers were sacrificed at the indicated ages
and genotyping of embryos was performed on liver DNA extracts. For geno-
typing, a c-kit genomic DNA fragment was amplified by PCR using the follow-
ing primers: 5′-CTGCTCATTGGCTTTGTGGT-3′ and 5′- CCTCGACAACC-
TTCCATTGT-3′. Subsequently the PCR product was digested with BfuAI,
which cuts only thewildtype sequence producing two fragments of 65 and 146 bp
in c-kit+/+ mice. The mutant sequence remains uncut producing a single 211 bp
fragment in c-kitW/W mice, while c-kitW/+ animals display all three fragments.
RNA extraction and real-time RT-PCR
To quantitate expression levels of mRNAs, real time RT-PCR was
performed. For SCF isoforms KL-1 and KL-2 in E11.5 kidneys, total RNA
was extracted from isolated ureteric buds and metanephric mesenchymes as
described previously (Schmidt-Ott et al., 2005). Briefly, after trypsinization of
E11.5 kidneys, ureteric buds and metanephric mesenchymes were micro-
dissected using minutien pins (Fine Scientific). RNA was extracted from
approximately 30 ureteric buds and 15 metanephric mesenchymes using
RNeasy Mini Kit with on-column DNase digest (Qiagen, Valencia, CA). To
detect c-kit, Flk-1, and sFRP1 mRNAs in cultured metanephric kidneys, E12.5
kidneys were freshly dissected and plated on transwell filters in the presence of
SCF or STI-571 as indicated. After 4 days of culture, kidneys were harvested
and total RNA was extracted. cDNA was synthesized using Omniscript®
Reverse Transcriptase (Qiagen). Primer pairs were designed to amplify the
membrane-associated form of SCF KL-1 (5′-ATAGTGGATGACCTCGTGGC-
3′ and 5′-TGCAACAGGGGGTAACATAA-3′), the secreted form of SCF KL-2
(5′-ATAGTGGATGACCTCGTGGC-3′ and 5′-GGCTTTCCCTTTCTCAG-
GAC-3′), c-kit (5′-GGCACAGAAGGAGGCACTTA-3′ and 5′-TTGGAGG-
CCTTACACTCCAC-3′), Flk-1 (5′-CAGCTTCCAAGTGGCTAAGG-3′ and
5′-CAGAGCAACACACCGAAAGA-3′), and sFRP1 (5′-TCAGAGGCCAT-
CATTGAACA-3′ and 5′-GCAGGTACTGGCTCTTCACC-3′). The resulting
fragments were verified by sequencing. The real-time PCR reaction contained
iQ™ SYBR® Green Super Mix (Biorad, Hercules, CA), 200 nM of each primer
and 0.2 μL of template in a 25 μL reaction volume. Amplification was carried
out using the MyiQ™ Single-Color Real-Time PCR Detection System (Biorad)
with incubation times of 2 min at 95°C, followed by 50 cycles of 95°C/30 s and
60°C/30 s. Specificity of the amplification was checked by melting curve
analysis and agarose gel electrophoresis. Relative levels of mRNA expression
were calculated according to the ΔCT method. Individual expression values
were normalized by comparison to β-actin mRNA expression using specific
primers (Schmidt-Ott et al., 2005).
In situ hybridization
In situ hybridization on frozen thin sections and whole-mount tissue were
performed using DIG-labeled probes as described previously (Mendelsohn et
al., 1999; Schmidt-Ott et al., 2005). To produce probes for c-kit and SCF, a
1.3 kB c-kit fragment and a 0.9 kB SCF fragment were cloned into pBluescript
KS(+) (Stratagene, La Jolla, CA), respectively. The resulting plasmids were
linearized and T3 polymerase was used to produce riboprobes, which were
subsequently fragmented by alkaline hydrolysis. Probes for Foxd1, sFRP1 and
Raldh2 were described previously (Batourina et al., 2001; Levinson et al., 2005).
Immunofluorescence
Embryos or whole mount tissues were fixed for 30 min using 4%
paraformaldehyde in PBS followed by incubation in 50 mM ammonia in PBS
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whole mounts were immediately processed for immunostaining. For c-kit
immunostaining, sections were stained using tyramide signal amplification
(TSA™-Plus Fluorescin System, Perkin Elmer, Boston, MA) with c-kit
monoclonal antibody ACK45 (BD Pharmingen) at 1:1000 (Botchkareva et al.,
2001). For other immunostaing reactions, whole mounts or tissue sections were
blocked with 0.2% bovine serum albumin/0.05% triton® X-100 in PBS and
stained using primary antibodies for Pax-2 (Invitrogen, Carlsbad, CA), WT-1
(C-19; Santa Cruz Biotechnology, Santa Cruz, CA), β-galactosidase (Biogen-
esis Inc., Kingston, NH), podocalyxin-like protein (R&D Systems, Minneapolis,
MN), Flk-1 (sc-315; Santa Cruz Biotechnology or Clone Avas12α1; BD
Pharmingen), pan-cytokeratin (FITC-labeled; Sigma-Aldrich, St. Louis, MO),
ACTIVE® caspase-3 (Promega, Madison, WI) and the appropriate secondary
antibodies labeled with either Cy2, Cy3 or Cy5 (Jackson ImmunoResearch
Laboratories, West Grove, PA).
Immunoblot analysis of phosphorylated c-kit
To detect phosphorylated c-kit in embryonic tissues, kidneys and gonads
were dissected from wildtype embryos at E12.5 and 5 kidneys were incubated in
DMEMwith or without 500 ng/ml recombinant SCF for 15 min at 37°C. Tissues
were immediately lysed in sample buffer containing 0.1 M Tris–HCl, pH 6.8,
3.3% (w/v) SDS, 12% (v/v) glycerol, 3% β-mercapto-ethanol, and 0.004% (w/
v) bromophenol blue, homogenized and boiled. Extracts were separated on
SDS-polyacrylamide gels and electrophoretically transferred to nitrocellulose
membranes (Bio-Rad). The membrane was blocked with 5% bovine serum
albumin in 20 mM Tris–HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20 and
probed with a 1:1000 dilution of phospho-c-kit antibody (Cell Signaling
Technology, Danvers, MA). Horseradish peroxidase-conjugated goat anti-rabbit
IgG (Jackson ImmunoResearch Laboratories) at a 1:5000 dilution was used as a
secondary antibody, and the signal was detected using Amersham ECL PlusTM
detection system (GE Healthcare Bio-Sciences, Piscataway, NJ).
Quantitation of ureteric bud tips, glomeruli, and angioblasts
Explants were evaluated after 4 days of culture with growth factors and
inhibitors as indicated. Ureteric bud branches were visualized by immunostain-
ing for cytokeratin. Glomeruli were detected by immunostaining for
podocalyxin, which reveals typical C-shaped aggregates of podocytes (Figs.
5C–F) that can be easily distinguished from hematopoietic cells and angioblasts,
which are also positive for this marker (Figs. 3E, F). Angioblasts were visualized
by immunostaining for Flk-1. Ureteric bud tips, glomeruli and Flk-1-positive
angioblasts were counted for matched kidneys from a given embryo and the
number in the control kidney was adjusted to 100%. For statistical evaluation,
numbers were compared between control and treated kidneys using 2-sided
Student's t test with a threshold of p<0.05 indicating statistical significance.
Results
Stem cell factor and c-kit are expressed in distinct domains
during early kidney development
We compared the expression profiles of microdissected
ureteric bud tips, ureteric bud stalks and metanephric mesench-
ymes from E12.5 mouse embryos using Affymetrix microarrays
(Schmidt-Ott et al., 2005). Cross-comparison to a second set of
microarrays from rat embryonic kidneys and functional
annotation of conserved transcripts led to the discovery of a
set of secreted ureteric bud-derived molecules, conserved in the
two species. One of these factors was SCF, the ligand of the
receptor tyrosine kinase c-kit. As predicted from the microarray
data, in situ hybridization for SCF mRNA in E11.5 and E15.5
mouse embryos revealed expression in tips and stalks of the
ureteric bud as well as in the Wolffian duct (Figs. 1A–C). Twodistinct isoforms of SCF have been previously described: KL-1,
which has an extracellular proteolytic cleavage site permitting
release of SCF from the cell surface, and KL-2, which is
normally not cleaved and remains associated with the cell
surface. Since the in situ hybridization probe for SCF detects
both isoforms, we performed real-time RT-PCR using isoform-
specific primers on microdissected ureteric buds and meta-
nephric mesenchymes from mouse E11.5 kidneys. This
revealed a 106±19-fold overexpression of KL-1 mRNA and a
17.7±3.6-fold overexpression of KL-2 mRNA in ureteric buds
compared to metanephric mesenchyme when normalized to β-
actin mRNA as an internal control. These data indicate that both
the membrane-associated and the secreted isoforms of SCF are
strongly enriched in the ureteric bud.
To determine expression of the SCF receptor c-kit during
kidney development, we performed in situ hybridization on
mouse E11.5 embryos. c-kit-positive cells were found in the
region ventral and lateral to the dorsal aorta, extending to the
periphery of the kidney (Fig. 1D). The highest density of c-kit
positive cells was localized around the entry point of the
ureteric bud into the metanephric mesenchyme, but addition-
ally a multicellular layer of c-kit-positive cells surrounded the
entire metanephric mesenchyme. Both of these cell populations
were localized outside of the nephron progenitors marked by
Pax-2 expression (Figs. 1E, F). To localize c-kit protein, we
performed immunofluorescence staining using a monoclonal c-
kit antibody (ACK45) (Botchkareva et al., 2001). This revealed
a virtually identical pattern of c-kit mRNA and c-kit protein at
E11.5 (Figs. 1G–I). At E13.5, c-kit-positive cells surrounded
the entire developing kidney (Figs. 1J–L). The cell density was
highest around the ureteric bud stalk and c-kit-positive cells
appeared to invade the interstitium of the developing kidney
following the branches of the ureteric bud. However, these
cells were not directly adjacent to the ureteric bud stalk, unlike
contiguous cells that are known to express Bmp-4 (Levinson et
al., 2005). In addition, newly arising S-shaped bodies
expressed c-kit (Figs. 1M–O). The ureteric bud tips were
also positive for c-kit at E10.5 (Figs. 2J, L), but c-kit staining
became weak at E11.5 (Figs. 1G, I) and disappeared by E13.5
(Figs. 1J, L).
c-kit does not colocalize with Foxd1-expressing stromal cells
c-kit expression in E13.5 kidneys (Fig. 2A) was reminiscent
of the distribution of renal stromal cells, which are marked by
the expression of the transcription factor Foxd1 (Hatini et al.,
1996; Levinson and Mendelsohn, 2003; Levinson et al., 2005).
In situ hybridization of Foxd1 and retinaldehyde dehydrogen-
ase 2 (Raldh2), two markers of cortical stroma, and secreted
frizzled-related protein 1 (sFRP1), a marker of capsular stroma
(Levinson et al., 2005), revealed the possibility of an overlap
of c-kit and stromal cells (Figs. 2B–D). To obtain colocaliza-
tion data on the cellular level, we examined mice heterozygous
for a knock-in of β-galactosidase into the Foxd1 locus
(Foxd1lacZ/+). These animals display normal kidney develop-
ment and β-galactosidase can be used as a marker for Foxd1-
positive stromal cells (Hatini et al., 1996; Levinson et al.,
Fig. 1. Localization of SCF and c-kit during early kidney development. In situ hybridization of whole mounts (A, B) and cryosections (C) for SCF mRNA reveals
expression in the ureteric bud at E11.5 (A) and E15.5 (C) in mouse embryos and in E12.5 kidneys cultured on filters for 3 days (B). In situ hybridization on
cryosections for c-kit (D) reveals staining in the peri-aortic region extending to the periphery of the developing kidney. The ureteric bud and the metanephric
mesenchyme are labeled by immunostaining for Pax-2 (E) on E11.5. Overlay of Pax-2 and c-kit domains (F) demonstrates distinct cell populations. (G–I) The result is
confirmed by immunofluorescence using a monoclonal c-kit antibody (G) and a Pax-2 antibody (H) indicating overlap of c-kit mRNA and c-kit protein at E11.5. At
E13.5 c-kit-positive cells are found in the medullary region and in a rim around the kidney (J–L). Additionally, S-shaped bodies are positive for c-kit (arrows) as
evidenced in a single confocal section (4 μm) using double-immunofluorescence of c-kit and the epithelial marker E-cadherin (M–O). c-kit staining in the ureteric bud
is weak at E11.5 and absent at E13.5. MM, metanephric mesenchyme; S, S-shaped body; UB, ureteric bud.
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kit and WT-1 revealed clearly distinct domains of expression
that distinguished c-kit from Foxd1 and WT-1 cells (Figs. 2E–
L). In sections cranial to the metanephros, c-kit was localized
ventral and lateral to the dorsal aorta extending ventrally into
the hindgut-associated mesenchyme (Figs. 2F, H). WT-1
positive cells were located ventral to the c-kit-domain in the
urogenital ridges (Figs. 2E, H). Foxd1/lacZ-positive cells were
dorsal to the c-kit domain with the highest density around the
somitic region (Figs. 2G, H). This regional distributionextended posteriorly to the level of the metanephric mesench-
yme with little intermixture of the Foxd1 domain and the c-kit
domain at this stage (Figs. 2I–L). With progression of kidney
development, the Foxd1 and c-kit expression domains
displayed progressive intermixture in the peripheral and
medullary compartment (Figs. 2M–O). However, within the
limits of comparing membrane-bound c-kit and nuclear Foxd1/
lacZ, there was usually no coexpression of these markers
(Figs. 2P–R). In support of these results, we found c-kit
expression to be substantially reduced in gene expression
Fig. 2. Cells expressing c-kit are distinct from Foxd1-expressing renal stromal cells. c-kit immunofluorescence on E13.5 mouse kidneys (A) reveals a staining pattern
reminiscent of renal stromal cells characterized by the expression of Foxd1 and Raldh2 (B, C). sFRP1 selectively labels capsule-associated stroma (D). Triple
immunostaining for WT-1 (Cy5), c-kit (FITC), and β-galactosidase (Foxd1; Cy3) in Foxd1lacZ/+ mice at E10.5 reveals distinct domains of expression in transverse
sections cranial to the metanephros (E–H) and at the level of the metanephric mesenchyme (I–L). Note expression of c-kit in the tips of the ureteric bud (UB) at this
early stage of kidney development (J, L). At E13.5 intermixture of c-kit and Foxd1/lacZ-positive cells is observed in the kidney cortex (M–O). However, on the cellular
level most c-kit-positive cells are negative for Foxd1 (arrows) (P–R). Cl, cloaca; DA, dorsal aorta; Gn, gonad; HM, hindgut-associated mesenchyme; Ki, kidney; MM,
metanephric mesenchyme; ND, nephric duct; UB, ureteric bud; Ur, Ureter; UGR, urogenital ridge.
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compared to surrounding cells (F. Wang and C. L. Mendel-
sohn, unpublished data). These results indicate that c-kit-
positive cells and Foxd1-positive stromal cells remain distinct
entities throughout kidney development.
A subset of the c-kit cells express angioblast markers
The c-kit-expressing cells in the developing kidney are
continuous with the aorta-gonad-mesonephros (AGM) cell
mass that extends from the mesonephros caudally towards
the metanephros. Expression of c-kit in a large number ofAGM cells has been documented by immunostaining and
knock-in of β-galactosidase into the c-kit locus in E11.5
mouse embryos, but the spatial relationship to the kidney has
not been characterized (Bernex et al., 1996; North et al.,
2002). It is well established that the c-kit-expressing cell
population in the AGM contains the first definitive
hematopoietic stem cells at E10.5 of mouse development
(Sanchez et al., 1996), as well as other stem cell types
including angioblasts, primordial germ cells and mesenchy-
mal stem cells (Bernex et al., 1996; Dzierzak, 2005; Mendes
et al., 2005; Tamura et al., 2002). To determine whether c-
kit-expressing cells in the developing kidney might contain
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(Podxl) and Flk-1 (Doyonnas et al., 2005; Gao et al., 2005;
Hara et al., 1999; Kabrun et al., 1997), two markers of
angioblast. Indeed, a subset of the c-kit population expressed
Podxl and Flk-1 at E11.5 and E13.5 in the embryonic kidney
(Fig. 3). However, the majority of c-kit cells (94±2% at
E11.5) did not express angioblast markers and conversely a
majority of the Podxl- and Flk-1-positive angioblasts
(76±11% at E11.5) were negative for c-kit, suggesting that
co-expression of c-kit with Flk-1 and Podxl is either cell
type- or cell stage-specific during maturation of vascular
progenitors.Fig. 3. A subset of c-kit-positive cells expresses angioblast markers. Double-immuno
reveals co-expression in a small subset of cells (yellow areas; arrowheads). Expressio
and glomeruli (Gl). Note that c-kit-positive cells are interior to the mesothelial lining
(FITC) and Flk-1 (Cy3), a specific marker of angioblasts, at E11.5 (D–F) and E1
mesenchyme; UB, ureteric bud; Ur, ureter.c-kit positive cells do not require c-kit signal transduction for
survival in vivo
To determine the effect of genetic disruption of SCF/c-kit
signalling in vivo, we examined the White Spotting (W) mouse
strain. These mice carry a naturally occurring point mutation in
c-kit which results in defective splicing (Nocka et al., 1990),
leading to a 78 amino acid deletion of the transmembrane
domain. This results in mislocalization of the mutated c-kit from
the plasma membrane to an intracellular pool and consequently
abolishes the SCF/c-kit interaction. Homozygous mutant
animals die perinatally due to severe anemia and displayfluorescence for c-kit (FITC) and Podxl (Cy3) at E11.5 (A–C) and E13.5 (G–I)
n of Podxl is not restricted to angioblasts and is also observed in mesothelia (Me)
(arrow). A similar pattern is observed with double-immunofluorescence for c-kit
3.5 (J, K). Gn, gonad; Gl, glomerulus; Me, mesothelium; MM, metanephric
244 K.M. Schmidt-Ott et al. / Developmental Biology 299 (2006) 238–249pigmentation defects, but appear morphologically normal until
E15.5, when paleness of the liver becomes notable as a result of
anemia. To assess kidney development before the onset of
anemia and its detrimental effect on global development, we
devised a PCR-based genotyping procedure based on a
restriction site that is eliminated in the mutant DNA sequence
(see methods section). Immunostaining of the homozygous
embryos for mutant intracellular c-kit (after tissue permeabili-
zation with Tween-20) revealed normal distribution of c-kit
positive cells in the kidneys, indicating that c-kit signaling is not
essential for survival of these cells in vivo (Fig. 4A).
Interestingly, c-kit immunoreactivity in ureteric bud tip cells,
which is lost in wildtype embryos after E10.5 is maintained at
high levels in c-kit mutants at E13.5 (Fig. 4A; arrowheads)
suggesting that c-kit signal transduction is necessary for down-
regulation of c-kit protein levels in these cells. Analysis of the
kidney architecture in c-kit mutants at E13.5 revealed no
apparent defect at this stage. Ureteric bud branching and theFig. 4. Normal distribution of c-kit cells in c-kitW/W mice up to E13.5. (A) At
E13.5, c-kitW/W mice carrying a homozygous inactivating mutation of c-kit
display a normal distribution of intrarenal c-kit cells (labeled by staining for
intracellular mutant c-kit) with a large medullary domain and a rim surrounding
the kidney (Ki). Note aberrant staining for c-kit in the tips of the ureteric bud
(arrowheads), which is absent in wildtypes at this stage (compare to Figs. 1 and
2). Pan-cytokeratin (CK) staining at E13.5 reveals normal ureteric bud
branching in c-kitW/W mutants (B). WT-1 and Pax-2 staining demonstrate
regular patterning and differentiation of the metanephric mesenchyme and its
derivatives (B, C). Podxl staining reveals normal patterning of the developing
vasculature at this stage (C). The renal stroma marked by in situ hybridization
for Foxd1 (D) and Raldh2 (E) is present in the regular distribution. Similarly, the
renal capsule marker sFRP1 is unaffected (F). For appearance of wildtype
kidneys compare to Figs. 1–3.conversion of the metanephric mesenchyme into nephrons were
unaffected (Figs. 4B, C) and the renal stroma and vasculature
were patterned normally (Figs. 4C–F; compare to Fig. 2). In
addition, kidney sizes were similar between mutants and
wildtypes (n=6) when normalized to total body size (data not
shown). These results indicate that SCF/c-kit signaling is
dispensable for maintenance of the c-kit-positive cell population
and early growth and patterning of the developing kidney
in vivo.
SCF/c-kit signaling in kidney organ culture determines the
extent of the c-kit domain, the number of angioblasts and
growth of the explant
While the preservation of intrarenal c-kit-expressing cells in
c-kit mutant embryos suggests the presence of redundant
survival signals in vivo, the same may not be true in vitro,
where it is possible to grow E12.5 mouse kidneys in the absence
of any exogenous growth factors. To evaluate SCF signaling in
this basal condition, we examined c-kit phosphorylation.
Western blots in freshly isolated E12.5 mouse kidneys revealed
low levels of phospho-c-kit, which were rapidly (within 15 min)
increased after addition of recombinant SCF (500 ng/ml). The
effect was comparable to that on E12.5 gonads, a known target
of SCF signaling (Fig. 5A). This indicates that endogenous
ureteric bud-derived SCF activates c-kit, but the c-kit popula-
tion can be maximally activated by supplying additional ligand.
This allows us to test the response to further activation or
inhibition of c-kit signaling. Because SCF induces proliferation
and survival of multiple cell types including hematopoietic stem
cells and primordial germ cells (Ashman, 1999), we first tested
a possible survival effect of SCF in the cultured kidney by
detecting activated caspase-3, a marker of apoptotic cells 24 h
after application of STI-571 (10 μM), an antagonist of c-kit
signal transduction. Notably, we observed widespread apoptosis
in the c-kit-positive cells in the presence of STI-571, while only
occasional cells became apoptotic in control media (Figs. 5B–
D). Accordingly, whole mount in situ hybridizations and real-
time RT-PCR of c-kit mRNA on explants grown for 5 days in
the presence of STI-571 revealed a reduction of intrarenal c-kit
expression, while conversely, supplementation with exogenous
SCF led to an increase of intrarenal c-kit expression and an
expansion of the c-kit positive domain (Figs. 5E–H). In
contrast, neither Foxd1-positive stromal cells (as determined
by Foxd1/lacZ staining in Foxd1lacZ/+ mice) (data not shown)
nor sFRP1-positive capsular cells (as determined by real time
RT-PCR; Fig. 5E) were depleted or expanded by these
treatments indicating a specific, dose-responsive survival
activity of SCF/c-kit signaling on c-kit-expressing cells.
Since the c-kit-positive interstitial cell pool contains angio-
blasts among other cells, we hypothesized that SCF might
expand the angioblast pool. By real-time RT-PCR, we found
upregulation of Flk-1 mRNA in cultures treated with SCF and
down-regulation after treatment with STI-571 (Fig. 5E).
Immunostaining for Flk-1 revealed an expansion of angioblasts
in explants after treatment with exogenous SCF, while treatment
with STI-571 reduced the number of angioblasts in the explants
Fig. 5. Effects of c-kit signaling on c-kit-positive cells and angioblasts in isolated embryonic kidneys. (A) Western blot for Tyr719-phosphorylated c-kit in freshly
isolated mouse E12.5 kidneys or gonads incubated in media with (SCF) or without (CON) 500 ng/ml recombinant SCF for 15 min. (B–D) STI-571, an inhibitor of c-kit
tyrosine phosphorylation, induces apoptosis in the c-kit-positive cell population in E12.5 kidneys cultured for 24 h. Staining for activated caspase-3 (a-Casp3; Cy5), a
marker of apoptotic cells, is strongly increased in kidneys cultured in the presence of STI-571 (10 μM) (C) compared to control conditions (B). The ureteric bud is
counterstained with a pan-cytokeratin antibody (CK; FITC). Double-immunostaining for a-Casp3 and c-kit reveals that apoptosis is selectively induced in the c-kit-
positive cell population after STI-571 treatment (D). (E) Quantitation of mRNA expression of c-kit, Flk-1, and sFRP1 by real-time RT-PCR in kidneys cultured for
4 days in control media (CON) and media supplemented with either 500 ng/ml of SCF or 10 μM STI-571. Data are normalized for β-actin expression. *p<0.05;
**p<0.01. (F–H) c-kit cells are expanded by treatment with 500 ng/ml SCF (G) for 4 days compared to control kidneys (F, note the presence of a strongly c-kit-
positive gonad) as detected by whole mount in situ hybridization for c-kit on explanted urogenital sheets (arrowheads outline the kidneys). Treatment with STI-571
leads to depletion of intrarenal c-kit cells with preservation of only a small periureteric population (H). (I–K) Flk-1-positive angioblasts (Flk-1; Cy3) are expanded by
treatment with SCF (J) for 4 days compared to control kidneys (I). Conversely, STI-571 depletes Flk-1-positive cells (K).
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tion of preexistent angioblasts or that it may cause the matura-
tion of c-kit-positive progenitors into the angioblast lineage.
Since interstitial cells are known to modulate kidney
development, we tested the effect of exogenous SCF and c-kit
antagonism on nephron development. When added to
transwell cultures, SCF led to a significant increase in the
number of ureteric bud tips and glomeruli compared to
controls after 4 days of culture (Figs. 6A–C). The effect was
specific to c-kit since it was blocked by addition of a c-kit-
neutralizing antibody (Figs. 6G–I). Furthermore, compared to
control cultures, addition of the c-kit antagonist STI-571
decreased the number of glomeruli and ureteric bud tips (Figs.
6D–F). These findings indicate that ureteric bud-derived SCF,
by modulating the c-kit-positive interstitial population,
regulates nephron development.Discussion
Three principle findings are made in this study: 1. c-kit
delineates a novel population of interstitial progenitors in the
developing kidney. These progenitors extend from the AGM to
the kidney and include, but are not limited to Flk-1-positive
angioblasts. The c-kit cells are distinct from the stromal
population marked by Foxd1 expression. 2. c-kit signal
transduction is not essential for survival of the c-kit-positive
cell population in vivo. 3. In metanephric organ culture in
defined media, the c-kit-positive cells become dependent on
SCF signaling, presumably because redundant survival signals
are eliminated. Exogenous SCF expands intrarenal c-kit cells,
which is associated with increased numbers of angioblasts and
accelerated nephron development. Conversely, c-kit antagonism
depletes interstitial c-kit cells through apoptosis, reduces Flk-1-
Fig. 6. SCF/c-kit signaling modulates ureteric bud branching and nephron number. Quantitation of ureteric bud tips (UB tips) and glomeruli in E12.5 kidney explants
grown with either 500 ng/ml recombinant SCF, 10 μMSTI-571, an inhibitor of c-kit signal transduction, or SCF and 50 μg/ml ACK45, a monoclonal c-kit-neutralizing
antibody. The ureteric bud is marked by pan-cytokeratin staining (CK; FITC). Glomeruli are labeled by podocalyxin staining (Podxl; Cy3). Kidneys grown in 500 ng/
ml SCF (B) are larger in size and develop an increased number of UB tips and glomeruli compared to matched control kidneys (A). Conversely, supplementation of
media with 10 μM STI-571 (E) leads to a smaller explant size, inhibition of ureteric bud branching and decreased glomerular number compared to controls (D). The
effect of SCF is blocked by the addition of a monoclonal c-kit-neutralizing antibody (ACK45, 50 μg/ml; H) when compared to a species-matched isotype control
antibody at the same concentration (IgG, 50 μg/ml; G), demonstrating specificity of the effect for c-kit-positive cells. Quantitative changes in ureteric bud tip number
and glomerular number in treated kidneys compared to matched control kidneys are visualized in panels C, F, and I. *p<0.05; **p<0.01.
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nephron number.
It is known from previous studies that a large periaortic c-kit-
positive population exists in the embryo between day E10.5 and
E12.5 (Bernex et al., 1996; Keshet et al., 1991; Manova and
Bachvarova, 1991; Motro et al., 1991; Orr-Urtreger et al.,
1990). The spatial correlation of these cells to the developing
kidneys has not been characterized and knowledge about c-kit
and SCF expression during kidney development is limited. Two
recent studies have described expression of c-kit in distal
tubules and collecting ducts in late developing and adult
kidneys (David et al., 2005; Miliaras et al., 2004). Also, c-kit
cells surrounding the ureter have been identified and were
shown to play a role in ureter morphogenesis and peristalsis
(David et al., 2005). In the current study, we have determined
the temporal and spatial pattern of c-kit-expressing cells during
early morphogenesis of the kidney. Our data reveal a novel
population of interstitial cells that are negative for the classicalstromal marker Foxd1. A Foxd1-negative cortical stromal
population was previously noted (Hatini et al., 1996), yet c-kit is
the first positive marker of these cells.
We can speculate about the origin of c-kit-positive intrarenal
cells by following the temporal and spatial pattern of the c-kit
domain during embryonic development. At E10.5, when
metanephric development is initiated by outgrowth of the
ureteric bud from the nephric duct, we found c-kit to be
expressed in a large periaortic domain dorsal to the WT-1-
positive cells of the urogenital ridge. This domain is in direct
contact with the newly forming metanephric mesenchyme (Fig.
2L) and is clearly distinct from that of the Foxd1-positive
stromal progenitors, which extend from the somitic area (Figs.
2H, L). While it is unclear, whether Foxd1 or c-kit comprise
bona fide lineage markers for cells deriving from these domains,
it is compelling to speculate that the intrarenal c-kit and Foxd1
cells are derived from those two distinct mesodermal domains.
Indeed, Foxd1-positive cells have been speculated to be
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(Levinson and Mendelsohn, 2003). Hence, the intrarenal c-kit
population, like the Foxd1-positive population, appears to
derive from an extrarenal source (Fig. 7).
Numerous studies have shown that the AGM region is an
early site of definitive hematopoiesis in the embryo and this site
first contains long-term reconstituting cells around E11.5
simultaneous with the onset of metanephric development.
Grafting experiments have demonstrated that cells from the
AGM region develop into hematopoietic, endothelial and other
mesenchymal cell types in hosts and c-kit is a classical marker
of hematopoietic stem cells (Dzierzak, 2005; Mendes et al.,
2005; Sanchez et al., 1996; Tamura et al., 2002). However, only
a small fraction of the c-kit cells express additional markers of
hematopoietic and vascular stem cells at any one time and by
lineage tracing only a subset of the c-kit population has been
shown to give rise to hematopoietic and vascular cells
(Dzierzak, 2005; Sanchez et al., 1996). In agreement with
these observations, we found that only a small subset of c-kit-
positive cells in the developing kidney expresses podocalyxin
and Flk-1 (Fig. 3), two markers of vascular progenitors
(Doyonnas et al., 2005; Hara et al., 1999; Kabrun et al., 1997;
Shalaby et al., 1997), suggesting that c-kit-positive cells
represent a broader population of progenitors.
To identify the role of these cells in the kidney, we
analyzed c-kitW/W mice, which display a severely compro-
mised c-kit signal transduction due to deletion of the c-kit
transmembrane domain and intracellular retention of c-kit
protein. However, our results indicate that c-kit signaling is
not required for maintenance of the intrarenal c-kit population
in vivo, since cells positive for intracellular c-kit are preserved
in the wildtype pattern in homozygous mutant kidneys. This is
in agreement with earlier studies on the periaortic c-kit-
positive cell population in c-kitlacZ/lacZ mice demonstrating
that c-kit/lacZ cells in this area were maintained despiteFig. 7. Hypothetical relation of intrarenal lineages with mesodermal domains (schem
(blue) in the developing metanephric kidney are derived from nephron precursors in t
(red) in the kidney are continuous with a Foxd1-expressing cell domain in the somi
expressing cells (green) in the kidney that become interspersed with the Foxd1-expre
region (PAR) of the E10.5 embryo. DA, dorsal aorta; NT, neural tube; ST, stroma.homozygous deletion of the c-kit gene (Bernex et al., 1996).
The survival of the c-kit cells in vivo may explain why the
morphology of the renal stroma, vasculature and capsule as
well as the nephron architecture in c-kitW/W mice is normal up
to day E13.5. Thus manipulation of c-kit signaling in vivo was
insufficient to provide insight into the action of these cells in
the kidney.
Conversely, in metanephric organ culture, SCF/c-kit
signaling became essential for maintenance of the c-kit
positive population, presumably because parallel survival
pathways were eliminated by separating the kidney from its
normal embryonic environment. Supplementation of exogen-
ous SCF expands the c-kit population in this setting, while c-
kit antagonism leads to depletion of these cells. Simulta-
neously, the number of angioblasts and parenchymal cells was
co-regulated in these experiments, indicating that SCF target
cells play a positive modulatory role in renal development.
One possibility for the action of SCF is that it acts by
increasing the number of intrarenal angioblasts, which are
known to positively regulate ureteric bud branching and
nephron differentiation (Gao et al., 2005; Tufro et al., 1999).
This might occur by stimulating the proliferation of the small
number of c-kit/Flk-1-double-positive angioblasts in the
explant. Additionally, SCF might provide a differentiation
signal to induce angioblastic markers in c-kit-positive
progenitors. A precursor–product relationship between c-kit-
positive and Flk-1-positive cells was previously documented in
studies of mesoderm differentiation into hemangioblasts in
vitro (Fehling et al., 2003; Lacaud et al., 2004). Alternatively,
c-kit-positive, Flk-1-negative cells may signal Flk-1 positive
cells in a paracrine rather than in a lineal manner. Consistent
with any of these possibilities, inhibition of c-kit signaling
with STI-571 resulted in depletion of the c-kit progenitors as
well as Flk-1 positive cells. While it is compelling to speculate
that SCF/c-kit signal acts by expanding angioblast such aatic diagram). The ureteric bud (UB) and the metanephric mesenchyme (MM)
he urogenital ridges (UGR) of the E10.5 embryo. Foxd1-expressing stromal cells
tic area of the E10.5 embryo suggesting a lineal relationship. In contrast, c-kit-
ssing stromal cells are continuous with a c-kit-positive domain in the periaortic
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positive cells in the setting of c-kit-stimulation. While
blockade of Flk-1 alone is not likely to ablate the c-kit/Flk-1
double positive population, a reagent such as VEGF coupled
to a toxin might be successful (Veenendaal et al., 2002).
Additionally, analysis using c-kit mediated activation of a
permanent lineage marker, e.g. by Cre-lox technology, could
definitively link the larger c-kit population with the c-kit/Flk-
1-double-positive subset and c-kit-negative/Flk-1-positive
angioblasts.
In sum, SCF/c-kit signaling may mediate cross-talk of the
branching ureteric bud and interstitial progenitor cells to
coordinate proportional growth of the two compartments.
While our results point to a critical role of the c-kit-expressing
progenitor pool in modulating kidney development, selective
depletion of this heterogenous cell population or its individual
descendants in vivo will be required to define the functions of
each cell type in the complex interstitial population of the
kidney.
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